Health News & Press Release Distribution

Health

APAC
Global

BOTTICELLI, THE INQUIETUDE AND THE BEAUTY - Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance

FLORENCE, Italy, May 15, 2023 /PRNewswire/ -- Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master of beauty. With his "Venuses," he unknowingly established a canon of perfection that closely reflects tha...

2023-05-15 16:20 2321

BOTTICELLI, THE INQUIETUDE AND THE BEAUTY - Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance

Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance

DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time...

2023-05-15 15:10 1929

TVM Capital Healthcare opens office in Riyadh, Saudi Arabia

DUBAI, UAE and RIYADH, Saudi Arabia, May 15, 2023 /PRNewswire/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced today the opening of a new office in the capital of theKingdom of Saudi Arabia. The purpose of the new office is t...

2023-05-15 14:00 3261

Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis

SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences ("Keymed", HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The collaborat...

2023-05-15 12:30 2462

Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index

HANGZHOU, China, May 15, 2023 /PRNewswire/ -- On May 12, MSCI, a leading provider of critical decision support tools and services for the global investment community, announced the results of theMay 2023 Index Review for the MSCI Equity Indexes. Zylox-Tonbridge (2190.HK, "the Company") is pleased...

2023-05-15 12:17 2222

Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma

ROCKVILLE, Md. and SUZHOU, China, May 15, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-05-15 08:00 3647

FDI World Dental Federation's Virtual Summit ON WORLD ENVIRONMENT DAY TO HIGHLIGHT Sustainable Dental Practices for a Greener Future

GENEVA, May 15, 2023 /PRNewswire/ -- FDI World Dental Federation (FDI) today announces its highly anticipated virtualSummit on Sustainability in Dentistry , taking place on World Environment Day, 5 June. Following the tremendous succe...

2023-05-15 07:00 2838

Novarad's VisAR Receives FDA Clearance for Augmented Reality Surgical Navigation in Spinal Surgery in Indonesia

SALT LAKE CITY, May 13, 2023 /PRNewswire/ -- Novarad's VisAR, a surgical navigation system that uses augmented reality, has received clearance from Indonesia's FDA for intraoperative use in stereotactic spinal surgery. VisAR is accurate for both open and minimally invasive surgery (MISS). This cut...

2023-05-13 00:23 3750

LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate

SHANGHAI, May 12, 2023 /PRNewswire/ -- LaNova Medicines Ltd. ("LaNova Medicines") announced today it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305, a pre-clinical stage antibody drug conjugate (ADC) targeting G protein-coupled receptor, class C...

2023-05-12 23:30 4092

Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore

GAITHERSBURG, Md., May 12, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Singapore Health Sciences Authority (HSA) has granted extended interim authorization and the Ministry of Heal...

2023-05-12 21:01 5529

Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion

SUZHOU, China, May 12, 2023 /PRNewswire/ -- Today, Crystal Pharmatech announced that the GMP manufacturing facility of their CDMO business unit – Crystal Formulation Services (CFS) has successfully passed a remote audit conducted by a US client. The audit, which lasted for four days, confirmed th...

2023-05-12 21:00 2277

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

SHANGHAI, May 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Beijing Zhongchao Boya Medical Technology Co., Ltd. ("Boya M...

2023-05-12 20:00 2609

CRM Trial Connect 2023: Minister of Health Malaysia, Dr. Zaliha Mustafa visits Taimei Technology's booth

SHANGHAI, May 12, 2023 /PRNewswire/ -- Taimei Technology, the digital platform for life science industry, attendedCRM Trial Connect 2023 held at the InterContinental Kuala Lumpur fromMay 11 to May 12, 2023. During the event, Dr. Zaliha Mustafa, Minister of Health Malaysia visited Taimei Technolog...

2023-05-12 19:36 4380

CRM Trial Connect 2023: Minister of Health Malaysia, Dr. Zaliha Mustafa visits Taimei Technology's booth

Ageing Asia and SUSS join forces to organise the world's biggest ageing festival in Singapore across 24-25 May 2023

Over 100 world's' top gerontech solutions and launch of inaugural SUSS Geronpreneurship Innovation Festival to promote successful ageingalong Singapore's International Ageing Week SINGAPORE, May 12, 2023 /PRNewswire/ -- Ageing Asia 2023 – The World Ageing Festival (14th Edition) is co-organised ...

2023-05-12 18:38 3201

FWD Group announces Group CFO transition

HONG KONG, May 12, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "the company") today announced that its Group Chief Financial Officer (CFO), Jon Nielsen, will be leaving the company to pursue a career opportunity in North America. Mr Nielsen has committed to remain with FWD Grou...

2023-05-12 17:51 3527

Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology

JINAN, China, May 12, 2023 /PRNewswire/ -- On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's immunotherapy bifunctional antibody, QL1706 (J Hematol Oncol. 2023May 8;16(1):50). This study is the...

2023-05-12 17:40 2152

Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center

CAMBRIDGE, Mass., May 11, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and provider of integrated solutions from "Idea to IND" (I to I™), announced today it has entered into a strategic collaboration agre...

2023-05-12 09:32 2245

Nefecon Included in the Reimbursement Drug List of "Beijing Puhui Health Insurance Program" as a First-in-Disease Therapy for IgA Nephropathy

SHANGHAI, May 12, 2023 /PRNewswire/ -- An imported version of Nefecon (budesonide) delayed release capsule has been added to the 2023 New Reimbursement Drug List of Specialized Medicines of the "Beijing Puhui Health Insurance Program." Nefecon is a first-in-disease treatment for adults with prim...

2023-05-12 07:40 4174

Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in RRMM and B-NHL and Donor-Derived CAR-T GC007g in B-ALL at EHA2023 Congress

First disclosure of data from Phase 1 study of the donor-derived allogeneic CAR-T GC007g shows 100% overall response rate (ORR) and a favorable safety profile for treatment ofrelapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Longer-term GC012F data in relapsed/refractory multip...

2023-05-12 05:28 2464

NewFish partners with Socius Ingredients to develop algae proteins for USA sports and active nutrition market

CHICAGO, May 11, 2023 /PRNewswire/ -- NewFish has entered into a co-development partnership agreement withChicago-based Socius Ingredients to commercialise microalgae proteins and specialized ingredients targeting the active nutrition market in theUSA. The active and sports nutrition market in t...

2023-05-12 03:52 1839

1 ... 252 253 254255256 257 258 ... 858